empa-kidney results: empagliflozin reduces kidney disease progression and cardiovascular deaths
Published 1 year ago • 7.2K plays • Length 1:52Download video MP4
Download video MP3
Similar videos
-
2:33
empa-kidney: introduction to the trial
-
7:23
empa kidney trial
-
1:06:22
empa kidney results: flozins for all ckd with dr will herrington
-
3:21
empa ckd - 3 min trial summary
-
57:22
emerging data from empa-kidney study
-
1:35
empa-kidney: meta-analysis results
-
5:38
esc tv on the road - #aha22 - dcp and empa-kidney trials
-
38:48
radcliffe & cardionerds @aha22: empa-kidney: empagliflozin & cv outcomes in patients with ckd
-
9:06
sglt2 inhibitors in chronic kidney disease
-
3:07
empa kidney final
-
1:08:25
webinar: overview of high impact clinical trials: empa-kidney and stop-acei
-
10:10
empa-kidney results
-
1:14
empa-kidney results november 2022
-
44:57
empa-kidney in context: expanding our understanding of sodium-glucose cotransporter 2 inhibition ...
-
1:24:14
empagliflozin & kidney disease: the empa-kidney study (live)
-
8:14
dapa-ckd: renal benefits of sglt2 inhibition in people with and without diabetes | hiddo heerspink
-
11:52
safety evaluation of empagliflozin for patients with type 2 diabetes and chronic kidney disease
-
19:55
improving renal outcomes with glucose-lowering therapy in the individualized management of t2dm
-
16:52
new treatments for diabetic kidney disease | jay shubrook & katherine tuttle